COVID-19 trials registries data warehouse

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43749

DR BALBIR KUMAR

drbalbir10@gmail.com

2020-10-28

Recruiting

RCT

Randomized

Parallel

Open label

single-center

Treatment

Age more than 18years , <br/ >COVID-19 positive(RT-PCR) <br/ >either sex <br/ >Symptomatic patient(fever, cough and breathing difficulty)

1. History of allergy to vitamin C <br/ >2. Pregnant females or breastfeeding mothers <br/ >3. Critical ill patient who are intubation and on mechanical ventilation <br/ >

2

Not reported

18

75

India

Mild/moderate disease at enrollment

2: Mild/moderate disease at enrollment

100

Improvement in illness can be assessed reduction in the grading (mild;moderate sever) of symptoms after l administration of vitamin C (5oomg; twice a day) in COVID19 patients. <br/ >Timepoint: maximum time is 14 days

| Declared number of arm (3.0) differs from found arms (4.0)

Phase 4

[{"arm_notes": "", "treatment_id": 1369, "treatment_name": "Vitamin c", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]